A 51Cr red cell survival study performed on a woman who developed anti‐Yta during pregnancy resulting in an extremely reduced lifespan of less than 12 h of incompatible cells. Laboratory tests indicated a ‘dangerous' immune type antibody. However, it did not cause hemolytic disease of the newborn. The discrepancy between the serological and biological behavior raises a question of clinical significance.
No takes yet. Share an insight, caveat, or question.
Göbel et al. (1974) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: